marketinsights

Breaking News: Scilex Holding Company Secures $17 Million in Registered Direct Offering!

Scilex Holding Company Enters into Definitive Agreement for Sale of Common Stock and Warrants Transforming the Treatment Landscape In a groundbreaking move, Scilex Holding Company has announced a definitive agreement with institutional investors for the purchase and sale of shares of its common stock, pre-funded warrants, and common warrants. This strategic decision marks a significant…

Read More

The Schall Law Firm Encourages Stockholders to Join in Fraud Case Against DMC Global Inc: A Call to Action!

Stay Focused and Profitable: A Reminder for DMC Global Investors Don’t Let a Class Action Lawsuit Blow Up Your Investments LOS ANGELES, CA / ACCESSWIRE / December 11, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against DMC Global Inc. (“DMC Global” or “the…

Read More

Atomic Wallet’s Bold Stance on XRP: Why 3 is Out of Reach

Atomic Wallet Sparks Controversy with XRP Predictions Atomic Wallet, a well-known non-custodial decentralized wallet, recently made waves with its bold predictions about XRP’s future. After previously expressing a sarcastic bullish stance on the cryptocurrency, the wallet platform raised concerns within the XRP community by suggesting that the digital asset might never reach the $3 mark…

Read More

Breaking News: Aduro Clean Technologies Exercises Over-Allotment Option for Second Time!

Breaking News: Aduro Clean Technologies Exercises Over-Allotment Option for Second Time! LONDON, Ontario, Dec. 11, 2024 (GLOBE NEWSWIRE) — Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower value feedstocks, like waste plastics, heavy bitumen, and renewable oils,…

Read More

KYTX Investor Alert: Robbins Geller Rudman & Dowd LLP Announces Opportunity for Kyverna Therapeutics Inc. Investors with Substantial Losses to Lead Class Action Lawsuit

Robbins Geller Rudman & Dowd LLP Announces Deadline for Lead Plaintiff in Kyverna Therapeutics, Inc. Class Action Lawsuit What You Need to Know SAN DIEGO, Dec. 11, 2024 (GLOBE NEWSWIRE) — Robbins Geller Rudman & Dowd LLP has announced that purchasers or acquirers of Kyverna Therapeutics, Inc. (NASDAQ: KYTX) common stock have until February 7,…

Read More